Recently, novel antineoplastics were developed by preferentially targeting inhibition of such EGFR tyrosine kinase.

• 近年来,许多以此为靶点的新抗肿瘤药物陆续被开发,在多种肿瘤治疗中取得了令人鼓舞的疗效。